JoanneBWeidhaasMDPHD, MSM

PubMed

• High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II C...
  Ting Martin Ma, Deborah J Wong, Wanxing Chai-Ho, Abie Mendelsohn, Maie St John, Elliot Abemayor, Dinesh Chhetri, Dipti Sajed, Audrey Dang, Fang-I Chu, Michael Xiang, R...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 May 2
• Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Em...
  Clayton P Smith, James A Proudfoot, Paul C Boutros, Robert E Reiter, Luca Valle, Matthew B Rettig, Nicholas G Nickols, Felix Y Feng, Paul L Nguyen, Himanshu Nagar, Dan...> ;European Urology Oncology. 2023 Apr 1
• Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial.
  Amar U Kishan, Nicholas Marco, Ting Martin Ma, Michael L Steinberg, Ankush Sachdeva, Minsong Cao, Leslie K Ballas, Emily Rietdorf, Donatello Telesca, Joanne B Weidhaas> ;Clinical and Translational Radiation Oncology. 2023 Mar 1
• 1 citations
  Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease.
  Miquel Ensenyat-Mendez, Dennis Rünger, Javier I J Orozco, Julie Le, Jennifer L Baker, Joanne Weidhaas, Diego M Marzese, Maggie L DiNome> ;Annals of Surgical Oncology. 2022 Aug 1
• ASO Visual Abstract: Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
  Javier I J Orozco, Julie Le, Miquel Ensenyat-Mendez, Jennifer L Baker, Joanne Weidhaas, Alexandra Klomhaus, Diego M Marzese, Maggie L DiNome> ;Annals of Surgical Oncology. 2022 Oct 1
• 4 citations
  Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
  Javier I J Orozco, Julie Le, Miquel Ensenyat-Mendez, Jennifer L Baker, Joanne Weidhaas, Alexandra Klomhaus, Diego M Marzese, Maggie L DiNome> ;Annals of Surgical Oncology. 2022 Oct 1
• Viral Burden and Clearance in Asymptomatic COVID-19 Patients.
  Avanka B Gunatilaka, Nicholas Marco, Graham H Read, Maggie Sweeney, Greg Regan, Cynthia Tsang, Lobna Abdulrahman, Swetha Ampabathina, Archie Spindler, Sarah S Lu, Elen...> ;Open Forum Infectious Diseases. 2022 May 1
• 3 citations
  Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.
  Amar U Kishan, Nicholas Marco, Melanie-Birte Schulz-Jaavall, Michael L Steinberg, Phuoc T Tran, Jesus E Juarez, Audrey Dang, Donatello Telesca, Wolfgang A Lilleby, Joa...> ;Radiotherapy and Oncology. 2022 Feb 1
• 8 citations
  Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy.
  Joanne Weidhaas, Nicholas Marco, Aaron W Scheffler, Anusha Kalbasi, Kirk Wilenius, Emily Rietdorf, Jaya Gill, Mara Heilig, Caroline Desler, Robert K Chin, Tania Kaprea...> ;Journal for Immunotherapy of Cancer. 2022 Feb 1
• A Phase 2 Study of 5-Day Preoperative Radiotherapy for Patients With High-Risk Primary Soft Tissue Sarcoma.
  Ricky R. Savjani, Scott D. Nelson, Sarah M. Dry, Mitchell Kamrava, J. Hernandez, N. Chong, Bartosz Chmielowski, Arun S. Singh, Joseph G. Crompton, Brooke Crawford, Sus...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
• 14 citations
  Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer
  Amar U. Kishan, Tahmineh Romero, Mohammed Alshalalfa, Yang Liu, Phuoc T. Tran, Nicholas G. Nickols, Huihui Ye, Dipti Sajed, Matthew Rettig, Robert E. Reiter, Isla P. G...> ;European Urology. 2020 Sep 1
• 2 citations
  Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radi...
  Luca F. Valle, Dan Ruan, Audrey Dang, Rebecca Levin-Epstein, Ankur P. Patel, Joanne B. Weidhaas, Nicholas G. Nickols, Percy Lee, Daniel A. Low, S Qi, Christopher R. Ki...> ;Frontiers in Oncology. 2020 May 20
• 36 citations
  A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.
  Anusha Kalbasi, Mitchell Kamrava, Fang-I Chu, Donatello Telesca, Ritchell van Dams, Yingli Yang, Dan Ruan, Scott D. Nelson, Sarah M. Dry, J. Hernandez, Bartosz Chmielo...> ;Clinical Cancer Research. 2020 Apr 15
• Identifying MicroRNA Pathway Variants as Biomarkers of Patient Selection for Immune Therapy.
  Joanne B. Weidhaas> ;Methods in Molecular Biology. 2020 Jan 1
• 15 citations
  Enhancing Career Paths for Tomorrow's Radiation Oncologists.
  Neha Vapiwala, Charles R. Thomas, Surbhi Grover, Mei Ling Yap, Timur Mitin, Lawrence N. Shulman, Mary Gospodarowicz, J.M. Longo, Daniel G. Petereit, Ronald D. Ennis, J...> ;International Journal of Radiation Oncology, Biology, Physics. 2019 Sep 1
• 4 citations
  Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
  Davide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, Rongze Lu, Karolina Palucka, Josue Samayoa, Stefani Spranger, Sarah Warren, Kwok-Kin Wong, Elad Ziv, Diego Cho...> ;Journal for Immunotherapy of Cancer. 2019 Jul 4
• 49 citations
  Toward a comprehensive view of cancer immune responsiveness: A synopsis from the SITC workshop
  Davide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, Rongze Lu, Karolina Palucka, Josue Samayoa, Stefani Spranger, Sarah Warren, Kwok-Kin Wong, Elad Ziv, Diego Cho...> ;Journal for Immunotherapy of Cancer. 2019 May 22
• 1 citations
  Patient-Reported Outcomes and Cosmesis in a Feasibility Study of 4-Dimensional Simulated Image Guided Accelerated Partial Breast Irradiation.
  Elham Rahimy, Joanne B. Weidhaas, Wei Wei, Donald R. Lannin, Nina R. Horowitz, Susan A. Higgins, Lynn D. Wilson, Christin A. Knowlton, Meena S. Moran, Melissa R. Young...> ;Practical Radiation Oncology. 2019 May 1
• 2 citations
  The KRAS-variant and its impact on normal breast epithelial cell biology.
  Song-Yi Jung, Poonam Malhotra, Kiana C Nguyen, David Salzman, Yue Qi, Ethan H Pak, Joshua King, Erina Vlashi, David K. Ann, Joanne B. Weidhaas> ;Cell Death and Differentiation. 2019 Apr 1
• 11 citations
  Breast Cancer and miR-SNPs: The Importance of miR Germ-Line Genetics
  Poonam Malhotra, Graham H. Read, Joanne B. Weidhaas> ;Non-Coding RNA. 2019 Mar 20
• 20 citations
  Functional microRNA binding site variants.
  Ye Yuan, Joanne B. Weidhaas> ;Molecular Oncology. 2019 Jan 1
• 1 citations
  Lack of an Association between a Polymorphism in the KRAS 3' Untranslated Region (rs61764370) and Endometriosis in a Large European Case-Control Study.
  Thomas D'Hooghe, Olga Grechukhina, SiHyun Cho, Amelie Fassbender, Dorien O, Daniëlle Peterse, Joanne B. Weidhaas, Hugh S. Taylor> ;Gynecologic and Obstetric Investigation. 2019 Jan 1
• 22 citations
  The patient's perspective on breast radiotherapy: Initial fears and expectations versus reality.
  Narek Shaverdian, Xiaoyan Wang, John V. Hegde, Criselda Aledia, Joanne B. Weidhaas, Michael L. Steinberg, Susan A. McCloskey> ;Cancer. 2018 Apr 15
• 8 citations
  MicroRNA signatures discriminate between uterine and ovarian serous carcinomas
  Pei Hui, Stefan Gysler, Mohamed Uduman, Taiwo A. Togun, Daniel Estévez Prado, Christine E. Brambs, Sunitha Nallur, Peter E. Schwartz, Thomas J. Rutherford, Alessandro ...> ;Human Pathology. 2018 Jun 1
• 5 citations
  Investigating the association of rs2910164 with cancer predisposition in an Irish cohort.
  Terri P. McVeigh, Robert J Mulligan, Una Mary McVeigh, Patrick W Owens, Nicola Miller, Marcia Bell, Frederic Sebag, Carole Guerin, Denis Quill, Joanne B. Weidhaas, Mic...> ;Endocrine Connections. 2017 Nov 1
• Join now to see all

Journal Articles

• A let-7 microRNA-Binding Site Polymorphism in KRAS Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab M...  
  Saridaki Z, Weidhaas JB, Lenz HJ, Laurent-Puig P, Jacobs B, De Schutter J, De Roock W, Salzman DW, Zhang W, Yang D, Pilati C, Bouche O, Piessevaux H, Tejpar S, Clin Cancer Res, 9/1/2014
• A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma  
  Chung CH, Lee JW, Slebos RJ, Howard JD, Perez J, Kang H, Fertig EJ, Considine M, Gilbert J, Murphy BA, Nallur S, Paranjape T, Jordan RC, Garcia J, Burtness B, Forastie..., Ann Oncol, 7/1/2014
• Radiation therapy oncology group gynecologic oncology working group: comprehensive results  
  Gaffney DK, Jhingran A, Portelance L, Viswanathan A, Schefter T, Weidhaas J, Small W Jr, Int J Gynecol Cancer, 6/1/2014
• Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society f...  
  Wallner PE, Anscher MS, Barker CA, Bassetti M, Bristow RG, Cha YI, Dicker AP, Formenti SC, Graves EE, Hahn SM, Hei TK, Kimmelman AC, Kirsch DG, Kozak KR, Lawrence TS, ..., Int J Radiat Oncol Biol Phys, 1/1/2014
• Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis  
  Kunos CA, Winter K, Dicker AP, Small W Jr, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB and Gaffney DK, Int J Gynecol Cancer, 5/1/2013
• SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers  
  Preskill, C. and Weidhaas, JB, Crit Rev Oncog, 1/1/2013
• The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer  
  Pilarski R, Patel DA, Weitzel J, McVeigh T, Dorairaj JJ, Heneghan HM, Miller N, Weidhaas JB, Kerin MJ, McKenna M, Wu X, Hildebrandt M, Zelterman D, Sand S, Shulman LP, PLoS One, 5/1/2012
• miRNAs in the spotlight: Making ‘silent’ mutations speak up  
  Salzman, DW, Weidhaas JB, Nature Medicine, 8/1/2011
• A variant in a microRNA complementary site in the 3’UTR of the KIT oncogene increases risk of acral melanoma  
  Godshalk SE, Paranjape T, Nallur S, Speed W, Chan E, Molinaro AM, Bacchiocchi A, Hoyt K, Tworkoski K, Stern DF, Sznol M, Ariyan S, Lazova R, Halaban R, Kidd KK, Weidha..., Oncogene, 3/1/2011
• An increase in the prevalence of the variant allele rs61764370 T>G in the 3’UTR of KRAS among Dutch BRCA1, but not BRCA2 and non-BRCA1/BRCA2 breast cancer families  
  Antoinette Hollestelle, Cory Pelletier, Maartje Hooning, Ellen Crepin, Mieke Schutte, Maxime Look, J. Margriet Collee, Anja Nieuwlaat, Lambert C.J. Dorssers, Caroline ..., BCRT, 1/1/2011
• MicroRNAs as Potential Diagnostics and Therapeutics  
  Trupti Paranjape, Jae Choi, Joanne B. Weidhaas, MicroRNAs in Cancer, 1/1/2011
• MicroRNA signatures differentiate uterine cancer tumor subtypes  
  E Ratner, D Tuck, C Richter, S Nallur, R Patel, V schultz, P Hui, P Schwartz, T Rutherford and J Weidhaas, Gynecologic Oncology, 1/1/2010
• Using microRNAs to understand cancer biology  
  Weidhaas, J, Lancet Oncology, 1/1/2010
• MicroRNA binding site polymorphisms as biomakers of cancer risk  
  Pelletier C, Weidhaas JB, Expert. Rev. Mol. Diagn, 1/1/2010
• Changes in Gene Expression Predicting Local Control in Cervical Cancer: Results from RTOG 0128  
  Weidhaas JB, S. Li, K. Winter, J. Ryu, A. Jhingran, B. Miller, A. P. Dicer, D. Gaffney, Clinical Cancer Research, 1/1/2009
• Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for the Optimization of Planning of Radiation Therapy  
  Kuo PH, Chen Z, and Weidhaas JB, Applied Radiology, 8/1/2008
• microRNA Modulation of the Cellular Stress Response  
  Imran A. Babar, Frank J. Slack, Weidhaas JB, Future Oncol, 1/1/2008
• MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy  
  Weidhaas JB, Imran Babar, Phong Trang, Sunitha M. Nallur, Sarah Roush, Michelle Boehm, Erin Gillespie and Frank J. Slack, Cancer Research, 1/1/2007
• A conserved Ras/Mitogen-Activated Protein Kinase Pathway Regulates DNA Damage-Induced Cell Death Postirradiation in Radelegans  
  Weidhaas JB, D.M. Eisenmann, J.M. Holub and S. Nallur, Cancer Research, 1/1/2006
• Relationship Between Gene Transcription and Retroviral DNA Integration  
  Weidhaas JB, E. Angelichio, S. Fenner and J.M. Coffin, J Virol, 1/1/1999
• Distribution of Targets for Avian Retrovirus DNA Integration In Vivo  
  S. Withers Ward, Y. Kitamura, Barnes JP, J.M. Coffin, Genes Dev, 1/1/1994
• Leukocyte Common Antigen-Related Receptor-Linked Tyrosine Phosphatase - Regulation of mRNA Expression  
  M. Longo, J.A. Martignetti, J.M. Le Beau, J.S. Zhang, Barnes JP, J. Brosius, J Biol Chem, 1/1/1993
• Hypothermia Protects Brain Function in Acute Carbon Monoxide Poisoning  
  B. Sutariya, D. Penney, Barnes JP, and C. Helfman, Vet Hum Toxicol, 1/1/1989
• Join now to see all

Lectures

• The KRAS-variant in Head and Neck Cancer as a Predictive Biomarker, results of RTOG 0522 
  6/1/2014
• MicroRNAs in cancer risk, biology and treatment 
  4/1/2014
• Yale Cancer Center Evening Oncology Series: Breast Cancer 
  Yale CME, New Haven, Connecticut - 1/17/2012
• The KRAS-variant in cancer 
  1/1/2012
• Being a Translational Researcher in Radiation Oncology 
  5/1/2011
• The potential of 3’UTR mutations in cancer 
  4/1/2011
• The KRAS-variant in HBOC 
  2/1/2011
• 3’UTR variants and cancer risk, a new paradigm 
  4/1/2010
• The KRAS-variant and MiRNA Biomarkers of Cancer Risk 
  2/1/2010
• MicroRNAs in Cancer Risk and Response 
  1/1/2010
• miRNA Binding Site Polymorphism and Ovarian Cancer Risk 
  11/1/2009
• Understanding miRNAs and cancer 
  9/1/2009
• The onco-SNP as a Biomarker of Ovarian Cancer Risk 
  5/1/2009
• A Single Nucleotide Polymorphism Disrupting MicroRNA Pathways and Predicting an Increased Risk for Ovarian Cancer 
  2/1/2009
• The microRNA let-7 and Lung Cancer 
  2/1/2008
• The Role of the EGFR-Pathway in Accelerated Repopulation after Radiation Therapy or Chemotherapy in C. elegans 
  2/1/2005
• A C. elegans In Vivo Model of Mitotic Cell Death and the Ras/MAPK Pathway 
  12/1/2003
• An In Vivo Tissue-Model of Post-Mitotic Cell Death and EGFR-Signaling in C. elegans 
  10/1/2003
• A C. elegans Model of Radiation Induced Post-Mitotic Cell Death 
  4/1/2003
• An In Vivo Tissue Model of Post-Mitotic Cell Death in C. elegans 
  1/1/2003
• Ras/MAPK-mediated Radiation Resistance in C. elegans 
  4/1/2002
• Transcriptional Activity Does Not Lead to Increased Retroviral Integration In Vivo 
  5/1/1997
• Join now to see all